Ironwood pharmaceuticals revenue
WebApr 10, 2024 · Ironwood Pharmaceuticals (NASDAQ:IRWD) has a market capitalization of $1.65 billion and generates $410.60 million in revenue each year. The biotechnology … WebAug 21, 2024 · Constipation Treatment Market Share, Growth, Statistics, By Application, Production, Revenue & Forecast To 2027 Ironwood Pharmaceuticals, Abbott, AstraZeneca 08-21-2024 07:37 AM CET ...
Ironwood pharmaceuticals revenue
Did you know?
WebApr 12, 2024 · From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $425.09 million. The company’s revenue is forecast to grow by 3.50% over what it did in 2024. A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Ironwood Pharmaceuticals Inc. WebAs of FY2024, Linzess was by far the most significant contributor to Ironwood's revenues, standing at USD 295.2m relative to total revenue of USD 298.3m. It should be noted that Linzess is not...
WebApr 14, 2024 · In other Ironwood Pharmaceuticals news, CEO Thomas A. Mccourt sold 46,129 shares of Ironwood Pharmaceuticals stock in a transaction dated Monday, March 27th. The shares were sold at an average ... WebAccording to Ironwood Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $0.42 B . In 2024 the company made a revenue of $0.41 B an increase …
WebApr 15, 2024 · Analysts have estimated the company’s revenue for the quarter at $100.05 million, with a low estimate of $99.3 million and a high estimate of $101 million. According to the average forecast, sales growth in current quarter could jump up 2.60%, compared to the corresponding quarter of last year. WebNov 9, 2024 · Ironwood Pharmaceuticals ( NASDAQ:IRWD) Third Quarter 2024 Results Key Financial Results Revenue: US$108.6m (up 4.7% from 3Q 2024). Net income: US$50.3m (down 9.9% from 3Q 2024). Profit...
WebIronwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company. ... Total Enterprise Value to Total Revenue (ttm) 3.33. Markets data provided by S&P and by Xignite.
WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. One in five Americans suffer from GI diseases, resulting in millions of hospital visits and tens of billions in healthcare costs each year. slow cooker nacho cheese dipWebIronwood Pharmaceuticals. 100 Summer Street. Suite 2300. Boston MA 02110. Entrance at the corner of Devonshire St. and Summer St. [email protected]. Tel – … slow cooker mushroom stroganoffWebIronwood Pharmaceuticals is a Pharmaceutical Manufacturing, Drug Manufacturing & Research, and Biotechnology company located in Cambridge, Massachusetts with … slow cooker nashville hot chickenWebApr 12, 2024 · Shares of IRWD opened at $10.77 on Wednesday. Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to ... slow cooker myerWebMar 24, 2024 · Ironwood Pharmaceuticals has 5 employees across 2 locations and $410.6 m in annual revenue in FY 2024. See insights on Ironwood Pharmaceuticals including … slow cooker napa cabbageWebSep 27, 2024 · P/E (5.61), EV/EBITDA (9.28), and Price/Sales (5.37) are 30-80% lower than the sector medians. Balance sheet of IRWD has been steadily improving over the past several years. Revenue has grown... slow cooker nachosWebAddress: 100 Summer St Ste 2300 Boston, MA, 02110-2156 United States See other locations Phone: Website: www.ironwoodpharma.com Employees (this site): Modelled Employees (all sites): Actual Revenue: $410.60 million Actual Sales Growth: -0.76% Net Income Growth: -66.87% Assets: $1,100 Fiscal Year End: DEC Year Started: Incorporated: slow cooker nachos recipe